Fiber2026

Microbiota-gut-brain axis in cerebral palsy: from mechanisms to interventions.

Xie Fei, Bai Chao, Xu Jian, Luan Xinping — Frontiers in medicine

Summary

This study explores the connection between gut health and brain function in children with cerebral palsy (CP). It suggests that imbalances in gut bacteria might contribute to various health issues experienced by children with CP, beyond their initial brain injury. The review discusses potential ways to improve these conditions, including dietary changes like increasing fiber intake.

AI-generated summary — read the original

Key points

Children with cerebral palsy often experience various health issues beyond their initial brain injury.
There's a growing understanding that the gut microbiome, the community of bacteria in our intestines, plays a role in these broader health challenges.
Maintaining a healthy gut, potentially through dietary changes like increasing fiber, might help manage some of these related symptoms.
More research is needed to confirm these connections and develop effective interventions.

What the study looked at

This review paper explored how the "microbiota-gut-brain axis" – the complex communication system between our gut bacteria, gut, and brain – might contribute to the various health challenges faced by children with cerebral palsy (CP). It aimed to understand if gut health issues are linked to the broader symptoms seen in CP, beyond the initial brain injury. This was a comprehensive review, meaning the authors synthesized and analyzed existing scientific literature and studies on the topic. They did not conduct new experiments or recruit participants themselves but rather drew conclusions from a wide range of previously published research concerning children with CP and their gut and brain health. The review found emerging evidence suggesting that children with CP often have an imbalanced gut microbiome, with less diversity and fewer beneficial bacteria. This imbalance might interact with CP through several biological pathways, potentially worsening symptoms like digestive problems, inflammation, and even affecting cognitive function. While promising, the review emphasizes that current evidence shows associations, not definitive cause-and-effect, and highlights the need for more robust, long-term studies, especially regarding interventions like dietary fiber, probiotics, and nutritional optimization.

Dietary takeaway

This review suggests that a healthy gut, supported by a diet rich in fiber, could be beneficial for managing some of the broader health challenges in conditions like cerebral palsy. Incorporating more fruits, vegetables, whole grains, and legumes into daily meals can help feed beneficial gut bacteria. However, it's important to remember that this is a review of existing research, and while promising, one study or review doesn't provide definitive answers for individual health outcomes.

Abstract

Cerebral palsy (CP) is the most common cause of chronic motor disability in childhood and arises from non-progressive injury to the developing brain. Despite the static nature of the primary lesion, children with CP frequently experience evolving gastrointestinal, nutritional, inflammatory, sleep, cognitive, and seizure-related comorbidities that substantially influence functional recovery and caregiver burden. The microbiota-gut-brain axis (MGBA) provides a biologically plausible framework linking these multisystem manifestations. Emerging evidence suggests that children with CP may exhibit reduced gut microbial diversity, depletion of short-chain fatty acid (SCFA)-producing taxa, enrichment of opportunistic bacteria, and microbiome remodeling related to diet, constipation, antiepileptic drug exposure, oral inflammation, and care patterns. Dysbiosis may interact with CP through epithelial barrier disruption, lipopolysaccharide translocation, systemic immune activation, altered tryptophan-kynurenine metabolism, abnormal bile acid and SCFA signaling, vagal and enteric nervous system pathways, hypothalamic-pituitary-adrenal axis dysregulation, and microglial priming. These mechanisms may create a self-reinforcing cycle in which early brain injury promotes gut dysfunction, gut dysfunction reshapes the microbiome, and dysbiotic immune-metabolic signals further amplify symptom burden. Current interventions, including nutritional optimization, constipation protocols, dietary fiber, probiotics, prebiotics, synbiotics, oral health management, and family-centered care, show promise for improving bowel symptoms and selected microbial or inflammatory indices. However, most clinical studies remain small, short-term, and focused on constipation rather than long-term neurodevelopmental outcomes. All CP-specific human evidence currently demonstrates association rather than causation; no study has established that dysbiosis initiates CP or causally drives its neurological phenotype. Accordingly, mechanistic pathways are presented as testable hypotheses, not validated causal mechanisms in CP. This review synthesizes current evidence on the MGBA in CP, outlines mechanistic pathways, evaluates therapeutic opportunities, and proposes future directions for biomarker-driven and stratified intervention trials.

View on PubMed →DOI: 10.3389/fmed.2026.1911417